BAG-1 and Bcl-2 in IL-2 signaling

Leukemia and Lymphoma

Volumn 30, Issue 5-6, 1998, Pages 483-491

  Adachi, Masaaki ^a   Torigoe, Toshihiko ^a   Takayama, Shinichi ^b   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BURNHAM INSTITUTE   (United States)

Author keywords

BAG 1; Bcl 2; IL 2; Signal transduction; Tyrosine phosphorylation

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN KINASE; RAPAMYCIN; RECEPTOR SUBUNIT; SERINE;

APOPTOSIS; CELL COUNT; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION; HUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE;

EID: 0031871808     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057561     Document Type: Review

References (57)

1. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A. and Oren, M. (1991). Wil-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin 6, Nature, 352, 345-347.
2. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B. and Costa, J. (1992). Induction of apoptosis by wild type p53 in a human colon tumor derived cell line. Proc. Natl. Acad. Sci. USA, 89, 4495-4499.
3. Oltari, Z., Milliman, C. and Korsmeyer, S. J. (1993). Bcl-2 heterodimers in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 609-619.
4. Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B. and Korsmeyer, S. J. (1995). Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell, 80, 285-291.
5. Boise, L. H., Gonzaaltz-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G. and Thompson, C. B. (1993). bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 1-20.
6. White, E., Cipriani, R., Sabbatini, P. and Denton, A. (1991). Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol., 65, 2968-2978.
7. Rao, L., Debbas, M., Sabbatini, P., Hockenbery, D., Korsmeyer, S. and White, E. (1992). The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA, 89, 7742-7746.
8. Tsujimoto, Y., Cossman, J., Jaffe, E. and Croce, C. (1985). Involvement of the bcl-2 gene in human follicular lymphoma. Science, 228, 1440-1443.
9. Reed, J. C. (1994). Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124, 1-6.
10. Lotem, J. and Sachs, L. (1993). Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation competent and defective myeloid leukemic cells. Cell Growth Differ., 4, 41-47.
11. Gooding, L. R., Elmore, L. W., Tollefson, A. E., Brody, H. A. and Wold, W. S. (1988). A 14,700 MW protein from the E3 region of adenovirus inhibite cytolysis by tumor necrosis factor. Cell, 53, 341-346.
12. Chou, J. and Roizman, B. (1992). The γ1 34.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthersis characteristic of programmed cell death in neuronal cells. Proc. Natl. Acad. Sci. USA, 89, 3266-3270.
13. Torigoe, T., Millan, J. A., Takayama, S., Taichman, R., Miyasita, T. and Reed, J. C. (1994). Bcl-2 inhibits T-cell-mediated cytolysis of a leukemia cell line. Cancer Res., 54, 4851-4854.
14. McDonnell, T. J., Deane, N., Platt, F. M., Numez, G., Jaeger, V., McKearn, J. P. and Korsmeyer, S. J. (1989). bcl-2 immunoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation. Cell, 57, 79-88.
15. Cleary, M. L., Smith, S. D. and Sklar, J. (1986). Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/ immunoglobulin transcript resulting from the t(14;18)translocation. Cell, 47, 19-28.
16. Adachi, M., Tefferi, A., Greipp, P. R., Kipps, T. J. and Tsujimoto, Y. (1990). Preferential linkage of BCL-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia. J. Exp. Med., 171, 559-564.
17. Hanada, M., Delia, D., Aiello, A., Stadtmauer, E. and Reed, J. C. (1993). Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood, 82, 1820-1828.
18. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Irie, S., Millan, J. A. and Reed, J. C. (1995). Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell, 80, 279-284.
19. Cazals-Hatem, D., Louie, D., Tanaka, S. and Reed, J. C. (1992). Molecular cloning and DNA sequence analysis of cDNA encoding chicken homolog of the Bcl-2 oncoprotein. Biochim. Biophys. Acta., 1132, 109-113.
20. Chen-Levy, S. and Cleary, M. L. (1990). Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. J. Biol. Chem., 265, 4929-4933.
21. Tanaka, S., Saito, K. and Reed, J. C. (1993). Structure-function analysis of the apoptosis-suppressing Bcl-2 oncoprotein: substitution of a heterologous transmembrane domain restores function to truncated Bcl-2 proteins. J. Biol. Chem., 268, 10920-10926.
22. Henderson, S., Huen, D., Rowe, M., Dawson, C., Johnson, G. and Rickinson, A. (1993). Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA, 90, 8479-8483.
23. Sato, T., Hanada, M., Bodrug, S., Irie, S., Iwana, N., Boise, L. H., Thompson, C. B., Golemis, E., Fong, L., Wang, H.-G. and Reed, J. C. (1994). Interaction among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA, 91, 9238-9242.
24. Zha, H., Aimé-Sempé, C., Sato, T. and Reed, J. C. (1996). Proapoptotic Protein Bax Heterodimerizes with Bcl-2 and Homodimerizes with Bax via a Novel Domain (BH3) Distinct from BH1 and BH2. J. Biol. Chem., 271, 7440-7444.
25. Rechsteiner, M. (1991). Natural substrates of the ubiquitin proteolytic pathway. Cell, 66, 615-618.
26. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D. and Korsmeyer, S. J. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed Cell death. Nature (Lond.). 348, 334-336.
27. Monaghan, P., Robertson, D., Amos, A.S., Dyer, J. S., Mason, D. Y. and Greaves, M. F. (1992). Ultrastructural localization of Bcl-2 protein. J. Histochem. Cytochem., 40, 1819-1825.
28. Krajewski, S., Tanaka, S., Takayama, S., Schibler, M. J., Fenton, W. and Reed, J. C. (1993). Investigations of the subcellular distribution of the BCL-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res., 53, 4701-4714.
29. Zhong, L.-T., Sarafian, T., Kane, D. J., Charles, C., Mah, S. P., Edwards, R. H. and Bredessen, D. E. (1993). bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA, 90, 4533-4537.
30. Hennet, T., Bertoni, G., Richter, C. and Peterhans, E. (1993). Expression of Bcl-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res., 53, 1456-1460.
31. Aagaard, K. M. and Jelinek, D. F. (1995). Differential activation of a calcium-dependent endonuclease in human B-lymphocytes. J. Immunol., 155, 3297-3307.
32. Linette, G. P., Li, Y., Roth, K. and Korsmeyer, S. J. (1996). Cross talk between cell death and cell cycle progression: Bcl-2 regulates NFAT-mediated activation. Proc. Natl. Acad. Sci. USA, 93, 9545-9552.
33. Shibasaki, F., Kondo, E., Akagi, T. and McKeon. F. (1997). Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature, 386, 728-731.
34. 2+-activated cell death in mammalian cells. J. Cell Biol., 131, 735-743.
35. Wang, H.-G., Takayama, S., Rapp, U. R. and Reed, J. C. (1996). Bcl-2 interracting protein, BAG-1. binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA, 93, 7063-7068.
36. Wang, H. G., Miyashita, T., Takayama, S., Sato, T., Torigoe, T., Krajewski, S., Tanaka, S., Hovey, L., Troppmair, J., Rapp, U. R. and Reed, J. C. (1994). Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene. 9, 2751-2756.
37. Wang, H.-G., Rapp, U. R. and Reed, J. C. (1996). Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell, 87, 629-638.
38. Zah, J., Harada, H., Yang, E., Jockel, J. and Korsmeyer, S. J. (1996). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell, 87, 619-628.
39. Takayama, S., Bimston, D. N., Matsuzawa, S., Freeman, B. C., Aime-Sempe, C., Xie, Z., Morimoto, R. I. and Reed, J. C. (1997). BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J., in press
40. Bardelli, A., Longati, P., Albero, D., Goruppi, S., Schneider, C., Ponzetto, C. and Comoglio, P. M. (1996). HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J., 15, 6205-6212.
41. Takeshita, T., Asao, H., Ohtani, K., Ishii, N., Kumaki, S., Tanaka, N., Munakata, H., Nakamura, M. and Sugamura, K. (1992). Cloning of the γ chain of the human IL-2 receptor. Science, 257, 379-382.
42. Hatakeyama, M., Mori, H., Doi, T. and Taniguchi, T. (1989). A restricted cytoplasmic region of IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization. Cell, 59, 837-845.
43. Shibuya, H., Yoneyama, M., Ninomiya-Tsuji, J., Matsumoto, K. and Taniguchi, T. (1992). IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell, 70, 57-67.
44. Reed, J. C., Tsujimoto, Y., Alpers, J. D. Croce, C. M. and Nowell, P. C. (1987). Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science, 236, 1295-1299.
45. Deng, G. and Podack, E. R. (1993). Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc. Natl. Acad. Sci. USA, 90, 2189-2193.
46. Miyazaki, T., Liu, Z.-J., Kawahara, A., Minami, Y., Yamada, K., Tsujimoto, Y., Barsoumian, E. L., Perlmutter, R. M. and Taniguchi, T. (1995). Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell, 81, 223-231.
47. Adachi, M., Sekiya, M., Torigoe, T., Takayama, S., Reed, J. C., Miyazaki, T., Minami, Y., Taniguchi, T. and Imai, K. (1996). Interleukin-2 (IL-2) upregulates BAG-1 gene expression through serine-rich region within IL-2 receptor βc chain. Blood, 88, 4118-4123.
48. Minami, Y., Nakagawa, Y., Kawahara, A., Miyazaki, T., Sada, K., Yamamura, H. and Taniguchi, T. (1995). Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. Immunity, 2, 89-100.
49. Miyazaki, T., Kawahara, A., Fujii, H., Nakagawa, Y., Minami, Y., Liu, Z.-J., Oishi, I., Silvennoinen, O., Witthuhn, B. A., Ihle, J. N. and Taniguchi, T. (1994). Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science, 266, 1045-1047.
50. Kawahara, A., Minami, Y., Miyazaki, T., Ihle, J. N. and Taniguchi, T. (1995). Critical role of the interleukin 2 (IL-2) receptor γ-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc. Natl. Acad. Sci. USA, 92, 8724-8728.
51. Hartley, K. O., Gell, D., Smith, G. C. M., Zhang, H., Divecha, N., Connelly, M. A., Admon, A., Lees-Miller, S. P., Anderson, C. W. and Jackson, S. P. (1995). DNA-dependent kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telengiectasia gene product. Cell, 82, 849-856.
52. Miyajima, M., Kitamura, T., Harada, N., Yokota, T. and Arai, K. (1992). Cytokine receptors and signal transduction. Annu. Rev. Immunol., 10, 295-331.
53. Miyajima, M., Nui, A. L.-F., Ogorochi, T. and Sakamaki, K. (1993). Receptor for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood, 82, 1960-1974.
54. Kinoshita, T., Yokota, T., Arai, K. and Miyajima, A. (1995). Suppression of apoptotic death in hematopoietic cells by signaling through the IL-3/GM-CSF receptors. EMBO J., 14, 266-275.
55. Miura, O., Nakamura, N., Quelle, F. W., Witthuhn, B. A., Ihle, J. N. and Aoki, N. (1994). Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoiein receptor in vivo. Blood. 84, 1501-1507.
56. Zhuang, H., Patel, S. V., He, T., Sonsteby, S. K., Niu, Z. and Wojchowski, D. M. (1994). Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2. J. Biol. Chem, 269, 21411-21414.
57. Zhuang, H., Niu, Z., He, T.-C., Patel, S. V. and Wojchowski, D. M. (1995). Erythropoietin-dependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negative forms of Jak2. J. Biol. Chem., 270, 14500-14504.